Zev Sthoeger

5.4k total citations
119 papers, 4.0k citations indexed

About

Zev Sthoeger is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Zev Sthoeger has authored 119 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Rheumatology, 44 papers in Immunology and 26 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Zev Sthoeger's work include Systemic Lupus Erythematosus Research (35 papers), Monoclonal and Polyclonal Antibodies Research (25 papers) and T-cell and B-cell Immunology (24 papers). Zev Sthoeger is often cited by papers focused on Systemic Lupus Erythematosus Research (35 papers), Monoclonal and Polyclonal Antibodies Research (25 papers) and T-cell and B-cell Immunology (24 papers). Zev Sthoeger collaborates with scholars based in Israel, United States and Italy. Zev Sthoeger's co-authors include Edna Mozes, Nicholas Chiorazzi, Westley H. Reeves, Ilan Asher, Daniel Elbirt, Heidy Zinger, R G Lahita, Molly Dayan, David Helfgott and L T May and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Zev Sthoeger

118 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zev Sthoeger Israel 33 1.8k 1.1k 877 595 565 119 4.0k
Thierry Martin France 33 2.2k 1.2× 1.3k 1.1× 1.3k 1.4× 488 0.8× 785 1.4× 152 5.2k
Michael J. Townsend United States 30 3.0k 1.7× 1.2k 1.1× 771 0.9× 675 1.1× 457 0.8× 53 4.6k
Paola Migliorini Italy 42 2.4k 1.3× 2.0k 1.9× 1.3k 1.5× 497 0.8× 1.1k 2.0× 183 5.2k
Annemieke M. H. Boots Netherlands 34 2.1k 1.2× 1.2k 1.1× 822 0.9× 564 0.9× 266 0.5× 100 3.9k
David E. Yocum United States 33 1.3k 0.7× 2.4k 2.2× 525 0.6× 472 0.8× 600 1.1× 89 4.8k
Seiji Minota Japan 34 1.5k 0.8× 1.4k 1.3× 920 1.0× 228 0.4× 481 0.9× 165 3.8k
Francesco Indiveri Italy 41 3.2k 1.8× 588 0.5× 823 0.9× 722 1.2× 440 0.8× 215 5.9k
Timothy R. D. J. Radstake Netherlands 39 2.5k 1.4× 1.5k 1.4× 1.3k 1.4× 669 1.1× 447 0.8× 174 5.4k
Yaakov Naparstek Israel 34 1.8k 1.0× 1.0k 0.9× 1.0k 1.2× 260 0.4× 938 1.7× 105 4.1k
Robert W. Hoffman United States 34 2.0k 1.2× 1.7k 1.6× 496 0.6× 605 1.0× 896 1.6× 92 3.8k

Countries citing papers authored by Zev Sthoeger

Since Specialization
Citations

This map shows the geographic impact of Zev Sthoeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zev Sthoeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zev Sthoeger more than expected).

Fields of papers citing papers by Zev Sthoeger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zev Sthoeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zev Sthoeger. The network helps show where Zev Sthoeger may publish in the future.

Co-authorship network of co-authors of Zev Sthoeger

This figure shows the co-authorship network connecting the top 25 collaborators of Zev Sthoeger. A scholar is included among the top collaborators of Zev Sthoeger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zev Sthoeger. Zev Sthoeger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahlab‐Guri, Keren, et al.. (2023). Modification of Allergen Subcutaneous Immunotherapy Safety Precautions and Systemic Allergic Reaction Rate Reduction. Immunotherapy. 15(16). 1389–1400. 1 indexed citations
2.
Asher, Ilan, et al.. (2022). Early childhood allergy linked with development of attention deficit hyperactivity disorder and autism spectrum disorder. Pediatric Allergy and Immunology. 33(6). 16 indexed citations
3.
Sthoeger, Zev, Amir Sharabi, Heidy Zinger, Ilan Asher, & Edna Mozes. (2018). Indoleamine-2,3-dioxygenase in murine and human systemic lupus erythematosus: Down-regulation by the tolerogeneic peptide hCDR1. Clinical Immunology. 197. 34–39. 3 indexed citations
4.
Sthoeger, Zev, Margalit Lorber, Elias Toubi, et al.. (2017). Anti-BLyS Treatment of 36 Israeli Systemic Lupus Erythematosus Patients.. PubMed. 19(1). 44–48. 13 indexed citations
5.
Mahlab‐Guri, Keren, et al.. (2016). Two case reports of severe myocarditis associated with the initiation of dolutegravir treatment in HIV patients. Medicine. 95(47). e5465–e5465. 4 indexed citations
6.
Sthoeger, Zev, Amir Sharabi, & Edna Mozes. (2014). Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus. Journal of Autoimmunity. 54. 60–71. 33 indexed citations
7.
Sthoeger, Zev, et al.. (2012). [Recurrent infections in an ITP patient treated with rituximab].. PubMed. 151(11). 617–9, 655. 2 indexed citations
8.
Levy, Itzchak, Zohar Mor, Emilia Anis, et al.. (2011). Men Who Have Sex With Men, Risk Behavior, and HIV Infection: Integrative Analysis of Clinical, Epidemiological, and Laboratory Databases. Clinical Infectious Diseases. 52(11). 1363–1370. 32 indexed citations
9.
Sthoeger, Zev, Amir Sharabi, Yair Molad, et al.. (2009). Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): Immunomodulation of gene expression. Journal of Autoimmunity. 33(1). 77–82. 44 indexed citations
10.
Sthoeger, Zev, et al.. (2007). The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE study.. PubMed. 9(6). 472–5. 12 indexed citations
11.
Ergas, David, et al.. (2006). Acute Q fever in Israel: clinical and laboratory study of 100 hospitalized patients.. PubMed. 8(5). 337–41. 29 indexed citations
12.
Sthoeger, Zev, et al.. (2002). Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus. Clinical & Experimental Immunology. 127(2). 393–398. 82 indexed citations
13.
Keysary, Avi, Zev Sthoeger, Israel Potasman, et al.. (1999). Serologic Evidence of Human Monocytic and Granulocytic Ehrlichiosis in Israel. Emerging infectious diseases. 5(6). 775–778. 26 indexed citations
14.
Sthoeger, Zev, Ella Evron, Sorel Goland, et al.. (1997). Anti‐p53 Autoantibodies in Colon Cancer Patients. Annals of the New York Academy of Sciences. 815(1). 496–498. 7 indexed citations
15.
Sthoeger, Zev, et al.. (1997). Severe Hepatotoxicity on Beginning Propylthiouracil Therapy. Journal of Clinical Gastroenterology. 24(4). 267–269. 12 indexed citations
16.
Tartakovsky, Boris, Bonnie L. Bermas, Zev Sthoeger, G M Shearer, & Edna Mozes. (1996). Immunology: Defective maternal--fetal interaction in a murine autoimmune model. Human Reproduction. 11(11). 2408–2411. 34 indexed citations
17.
Evron, Ella, et al.. (1995). Correlation between gold‐induced enterocolitis and the presence of the HLA‐DRB 1*0404 allele. Arthritis & Rheumatism. 38(6). 755–759. 9 indexed citations
18.
Sthoeger, Zev, Edna Mozes, & Boris Tartakovsky. (1993). Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation.. Proceedings of the National Academy of Sciences. 90(14). 6464–6467. 111 indexed citations
19.
Sthoeger, Zev, et al.. (1991). Transient anticardiolipin antibodies, functional protein S deficiency, and deep vein thrombosis. American Journal of Hematology. 36(3). 206–207. 14 indexed citations
20.
Reeves, Westley H. & Zev Sthoeger. (1989). Molecular Cloning of cDNA Encoding the p70 (Ku) Lupus Autoantigen. Journal of Biological Chemistry. 264(9). 5047–5052. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026